 |
|
|
|
|
|
|
| Article 1 to 9 out of 9 concerning Biotage AB
|
-
Biotage AB and McMaster University sign two year extension to Molecular Imaging Development Agreement
(06 Mar 2008)
Biotage AB and McMaster University sign a two year extension to Molecular Imaging Development Agreement. McMaster University has successfully completed the first year research agreement, with a key journal publication and several technical ...
-
Biotage AB Increases Focus on Environmental Market Segments
(21 Feb 2008)
Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application ...
-
Biotage open up new business area: Molecular Imaging
(21 Jun 2007)
Molecular Imaging is an emerging market that is playing an important role to the ongoing worldwide efforts at improving health care and cost saving in the Pharma Industry. Biotage entered into a Molecular Imaging collaboration with McMaster ...
-
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform
(28 Feb 2007)
Biotage AB and McMaster University signed a joint agreement to develop a new chemistry platform to speed the production of molecular imaging and therapy agents. As part of the agreement, Biotage will provide funding and instruments. The McMaster ...
-
Biotage Makes a Change in Top Management after Business Area President resigns
(02 Mar 2006)
The life science company Biotage, listed on the O-list of the Stockholm stock exchange, makes a change in its top management. David Patteson, President of the business area Discovery Chemistry has decided to seek new challenges elsewhere. He will ...
-
Biotage AB Acquires Separtis Holding AG for 1.4M Euros (13M SEK) and Completes EU Distribution Consolidation
(11 Oct 2005)
Biotage has acquired Separtis Holding AG, the Swiss, German and Austrian distributor for many Biotage products, formerly the Argonaut Technologies consumable product range. Under the terms of the agreement Biotage will retain all current Separtis ...
-
Biotage has received its largest order to date
(15 Aug 2005)
Biotage has received the company's largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the world's major pharmaceutical companies. The instruments, which originate from the recently acquired ...
-
Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage
(03 Jun 2005)
Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its ...
-
Biotage receives largest committed order in history
(08 Jun 2004)
Biotage received the company's largest committed order in history to one of the largest pharmaceutical companies in the world. The order value represents approximately 1.5 MUSD. The order comprises a minimum of 53 instruments including the new ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon